Exhibit 10.06


 





 


CONFIDENTIAL


 








	CONFIDENTIAL
TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND,
WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL MATERIAL HAS BEEN
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.



 


 


Amendment #1 to IP LICENSE
AGREEMENT


 





THIS AMENDMENT #1 TO THE IP LICENSE AGREEMENT (“First
Amendment”) is made and entered into as of March 21, 2016 (the “First Amendment Effective Date”) by
and between Amyris, Inc., having its principal place of business located at 5885 Hollis St, Suite 100, Emeryville, CA 94608
USA (“Amyris”), and Novvi LLC, a Delaware limited liability corporation, having its place of business
at 5885 Hollis Street, Suite 100, Emeryville, California 94608 (“Novvi LLC”).


 





WHEREAS, Amyris and Novvi LLC entered into that certain
IP License Agreement on March 26, 2013 (the “License Agreement”) whereby Amyris agreed to license, on the terms
and conditions set forth in the License Agreement, certain of its intellectual property rights to Novvi LLC;


 


WHEREAS, such License Agreement was clarified by Novvi LLC, Total
Amyris BioSolutions B.V. (“TAB”), and Amyris in an Amended and Restated Letter Agreement Containing Clarifications
to the IP License Agreement dated November 30, 2013, which stated that certain By-Products would be sold only to Amyris or TAB,
and Novvi LLC would retain the ability to sell other By-Products to third parties;


 


WHEREAS, pursuant to the terms and conditions of this First
Amendment, the Parties desire to amend the License Agreement to clarify that Novvi LLC may offer for sale or sell its By-Products,
including Diesel By-Products, for any use excluding any use in or as (i) diesel fuel in the European Union and (ii) jet fuel worldwide.


 


NOW THEREFORE, in consideration of the promises and the mutual
covenants contained herein, the Parties agree as follows:


 


		1.	The Parties add the following new definition to Article 1 of the License Agreement:



 


““European Union” means those
countries that were members of the European Union as the effective date of Amendment #1 to the IP License Agreement, which countries
are listed on Exhibit A to such amendment.”


 


		2.	Section 2.1(a)(ii) of the License Agreement is revised to provide in its entirety as follows:



 


“(ii) subject to the limitations in Article 4
restricting the sale of By-Products for use in or as (i) diesel fuel in the European Union and (ii) jet fuel worldwide, a non-exclusive,
worldwide, royalty-free, non-sublicensable, and non-assignable license under Amyris Base Technology to offer for sale, sell, and
import any By-Products.”


 


For clarity, other than the specific changes to clause
(ii) set forth above, the remainder of Section 2.1(a) of the License Agreement, including clause (i) and the two paragraphs immediately
following the amended text above, remains as is and is not deleted, modified, or amended hereby.


 


		3.	Article 4 of the License Agreement is hereby amended by deleting such Article in its entirety and
replacing it with the following new Article 4:



 


“ARTICLE 4


 


SALE OF BY-PRODUCTS 


 


4.1      No Sale of By-Products as
Diesel Fuel in the European Union. Novvi LLC agrees that it shall not, at any time, offer for sale or sell any By-Products,
including, but not limited to, any farnesane or diesel-related By-Products (“Diesel By-Products”), for use in
or as diesel fuel in any of the European Union.


 


4.2      No Sale of Jet Fuel By-Products
except to Amyris; Amyris’s Obligation to Purchase.


 



    	 	Page 1 of 4	 



     

    




(a)                
Novvi LLC agrees that it will not offer for sale or sell any Jet Fuel By-Products to any person or entity except to Amyris as set
forth in this Section 4.2, and Amyris agrees that it will purchase all such Jet Fuel By-Products. As used in this Section, “Jet
Fuel By-Product” means a By-Product (i) whose concentration of farnesane, partially hydrogenated farnesene or farnesene,
by volume, is at least [*] or greater; and (ii) that when blended with petroleum-derived jet fuel, meets the ASTM D1655 and D7566
specifications (or successors thereto) for use as a jet fuel.


 


(b)                
The purchase price payable by Amyris to Novvi LLC for each liter of any Jet Fuel By-Product will be equal to the price per liter
that Amyris sells farnesene to Novvi LLC, in case such price is higher than [*] per liter. If the per liter of farnesene price
Amyris charges to Novvi LLC is below [*] per liter, Amyris will purchase such Jet Fuel By-Product at the NYMEX ULSD diesel one-month
forward price.


 


(c)  In connection with the
sale of any By-Products by Novvi LLC to a third party, Novvi LLC shall require any such purchaser to agree in writing that (i)
such By-Products may not be used in or as diesel fuel in the European Union or in or as jet fuels anywhere, and (ii) if any such
By-Products are incorporated into any diesel fuel outside the European Union, that such diesel fuels may not be imported into any
of the European Union.


 


(d)  Other than as set forth
in this Section, Amyris has no obligation or rights to purchase any By-Products from Novvi LLC.


 


4.3No Other Limits on Novvi LLC. Other
than as set forth in this Article 4, Novvi LLC may, pursuant to its license in Section 2.1(a)(ii), freely offer for sale,
sell, and import its By-Products.


 


		4.	Capitalized terms used in this First Amendment shall have the same meaning as defined in the License
Agreement unless otherwise defined herein. Except as specifically provided in this First Amendment, the terms and conditions of
the License Agreement shall remain in full force and effect. Together, the License Agreement and this First Amendment constitute
the entire agreement between the Parties with respect to the subject matter, and supersede any and all prior negotiations, representations,
correspondence, understandings and agreements with respect to the subject matter. To the extent of any conflict between the License
Agreement and this First Amendment, this First Amendment shall supersede and govern. This First Amendment may be executed in counterparts,
which together shall constitute one document and be binding on all of the Parties.



 


 


[THE REMAINDER OF THIS PAGE IS INTENTIONALLY BLANK]


 


 


 


 


[*] Certain portions denoted with
an asterisk have been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions.


 


 






    	 	Page 2 of 4	 



     

    

 


IN WITNESS WHEREOF, and intending to be bound by the provisions
hereof, the Parties have caused this First Amendment to be executed personally or by their duly authorized representatives, to
be effective as of the First Amendment Effective Date.


 





	AMYRIS, INC. 	 	NOVVI LLC	 
	 	 	 	 	 	 
	/s/ Nicholas Khadder	 	/s/ Jeffrey Brown	 
	By:	Nicholas Khadder	 	By:	Jeffrey Brown	 
	Title:	General Counsel	 	Title:	President & CEO	 
	 	 	 	 	 	 
	 	 	 	/s/ John L. Carnahan	 
	 	 	 	By:	John L. Carnahan	 
	 	 	 	Title:	Chief Operating Officer	 







 


 


 


 


 


 


 


 


 


 


 


 






    	 	Page 3 of 4	 



     

    

 


Exhibit A


 


Definition of European Union


 


 


 


		1.	Austria






		2.	Belgium






		3.	Bulgaria






		4.	Croatia






		5.	Cyprus






		6.	Czech Republic






		7.	Denmark






		8.	Estonia






		9.	Finland






		10.	France






		11.	Germany






		12.	Greece






		13.	Hungary






		14.	Ireland






		15.	Italy






		16.	Latvia






		17.	Lithuania






		18.	Luxembourg






		19.	Malta






		20.	Netherlands






		21.	Poland






		22.	Portugal






		23.	Romania






		24.	Slovakia






		25.	Slovenia






		26.	Spain






		27.	Sweden






		28.	United Kingdom



 


 


 


 


 


Page 4 of 4